A consensus guideline for the management of tissue filler-induced vision loss has been published in the Aesthetic Surgery Journal.
The guideline outlines clear recommendations on emergency management, access to specialist care, informed consent and awareness of vision-related risks associated with dermal fillers.
Developed by a multidisciplinary steering group, the guidance advises that practitioners performing tissue filler injections should have an emergency kit available to manage vision loss/ischaemic complications. It is also advised that practitioners should ensure consent explicitly includes the risk of vision loss, and initiate appropriate non-invasive measures in cases of filler-induced vision loss to help dislodge an embolus and restore retinal perfusion.
Consultant ophthalmologist and vitreoretinal surgeon Mr James Neffendorf, who played a leading role in the multidisciplinary steering group, commented, “We have written this peer-reviewed publication to help injectors understand the risk of vision loss after dermal filler injections and provide guidance on management. There are a series of clear recommendations that have been produced by our expert multidisciplinary panel, including aestheticians, a dermatologist, a pharmacist and ophthalmologists specialising in oculoplastics, emergency eye care and retina.”